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Abstract
Background: Estimation of the frequency of latent tuberculosis infection (LTBI) is difficult in areas
with low tuberculosis infection rates and high exposure to non-tuberculous mycobacteria (NTM),
including BCG vaccination. The objective was to assess LTBI and M avium infection and to estimate
their probability based on skin tests responses in an infant population from a region with the
aforementioned characteristics.
Methods:  A population-based tuberculin skin test (TST) and sensitin (M avium) survey was
conducted on seven years old infants in Biscay, a province from The Basque Country (Spain). 2268
schoolchildren received sensitin and 5277 TST. Participation rate was 89%. Commonly used
estimation methods were compared with a method based on the fit of mixture models using the
Expectation Maximization algorithm. Functions estimating the probabilities of LTBI and M avium
infection given the observed skin tests responses were developed for vaccinated and unvaccinated
children.
Results: LTBI prevalences varied widely according to the estimation method. The mixture model
provided prevalences higher than expected although intermediates between those obtained by
currently recommended approaches. Exposure to previous BCG vaccine produces an upward shift
of an average of about 3 mm on the induration size to attain the same probability of infection.
Conclusion: Our results confirm the commonplace exposure to NTM which effect should be
taken into account when performing and assessing tuberculin surveys. The use of mixture analysis
under the empirical Bayes framework allows to better estimate the probability of LTBI in settings
with presence of other NTM and high BCG-vaccination coverage. An estimation of the average
effect of BCG vaccination on TST induration is also provided. These models maximise information
coming from classical tuberculin surveys and could be used together with the newly developed
blood tests to improve survey's specificity and cost-effectiveness.
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Background
Tuberculosis is a well-recognised worldwide health prob-
lem [1]. However, the picture differs dramatically depend-
ing on the socioeconomic development of the area in
question. While in developing countries tuberculosis is
still a first order challenge, it is being kept increasingly
under control in developed countries. In the latter, the
diagnosis and treatment of Latent Tuberculosis Infection
(LTBI) is now necessary in order to eliminate tuberculosis
[2]. New blood tests [3,4] are already changing the
approach to this problem, and are to be implemented in
the near future in western industrialised countries. How-
ever, tuberculin skin tests (TST) remain today the most
used tools for LTBI diagnostic [5] and treatment [2] deci-
sions at a global scale.
Unfortunately, the interpretation of TST results suffers
from several drawbacks when performed on populations
where the BCG vaccination rate is high [6]. This situation
becomes even more awkward when cross-reactivity due to
infection with nontuberculous mycobacteria (NTM) is
present [7,8] (a subject which has not been addressed
much so far) and the survey is carried out in a region with
low tuberculosis prevalence [9].
In the region under study, a province in the Basque Coun-
try (Spain), all the aforementioned characteristics that
make the interpretation of TST results difficult are present.
The Basque Country is the only community that has had
a programme of systematic BCG vaccination in use for
more than two decades [10], in spite of being one of the
communities with the highest socioeconomic level.
Despite the current debate regarding whether it is appro-
priate to maintain this policy in our region due to a sub-
stantial decline in tuberculosis prevalence rates, methods
that allow a continuous and accurate monitoring of LTBI
in settings of this kind are still required.
Several statistical approaches have been attempted to cope
with the confounding effect of NTM infection (BCG vacci-
nation included) in the accurate estimation of LTBI. Tra-
ditionally, methods that propose fixed general cut-off
points have been in use [11-14]. However, problems in
determining the prevalence of LTBI using these methods
have long been recognised, making the exploration of
new statistical methods [7] necessary. Along these lines,
Neuenschwander et al. [15-17] have applied the so-called
mixture model analysis [18] to this problem, first focusing
on unvaccinated individuals and then extending this
approach to BCG-vaccinated subjects. They have shown
mixture models to be a flexible tool for analysing data of
this kind.
The purpose of the present study is threefold: a) to esti-
mate the prevalence of LTBI and Mycobacterium avium (M
avium) infection in the infant population of The Basque
Country (Spain), b) to find a method that could help us
to accurately discriminate LTBI from infection with other
mycobacteria, including BCG vaccination and c) to help
determine the probability of LTBI and M avium infection
according to tuberculin or sensitin induration sizes
respectively.
Methods
Population and sample size
The region under study is called Biscay, a province of The
Basque Country with a population of 1.2 million inhabit-
ants. In 1997, 13 smear-positive sputum cases among the
total 38 incident tuberculosis cases per 100,000 popula-
tion were notified in the region [19]. Our study popula-
tion consisted of all children living in Biscay and turning
seven years of age during 1998. We decided to study
school-age children based on two grounds: to allow for an
effect of the BCG vaccination to still be present and acces-
sibility criteria. This accounts for 8430 children.
To estimate the required sample size, we used results from
a previous survey in the same region [20]. A vaccination
coverage rate of 89%, a participation rate of 80%, a maxi-
mum prevalence of 20% among BCG-vaccinated and 2%
among unvaccinated children, respectively, with TST
induration size ≥ 10 mm were anticipated. Standard errors
of 0.4 and 0.35% were respectively accepted for the prev-
alence estimations. A required sample size of 6250 chil-
dren was obtained, a quantity close to the total
population size assuming a recruitment rate of 80%, so
eventually we decided to recruit as many schoolchildren
as possible, since the study could provide the potential
benefit of detecting additional children with very large
indurations, requiring further examination in order to
assess the need for prophylactic treatment.
Survey design
This study focuses on some aspects of a more general
research project devoted to investigate the distribution of
tuberculin and sensitin induration sizes as well as the rela-
tionship among them and the so-called booster effect. In
order to accomplish this endeavour, recruited children
were randomly distributed in three groups. Two thirds
received tuberculin as the first test and one third received
the M avium sensitin, which was the most prevalent MNT
in our region at the study time (data provided by the
Basque Country Public Health Department). Out of the
children receiving tuberculin as the first test, half were
given a repeat dose of tuberculin one week later, and half
were given the sensitin. Children who had received the
sensitin as the first test were given a tuberculin one week
later. In this paper, only results regarding administration
of the first skin test are shown.BMC Public Health 2006, 6:240 http://www.biomedcentral.com/1471-2458/6/240
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The field work was planned to be conducted in 5 months
so as to prevent substantial changes in the children's char-
acteristics and personnel involved in the process that
could influence results.
Firstly, an informative campaign among parents and
teachers was conducted, presenting the aim and methods
of the study, and encouraging them to participate. In addi-
tion, an informative leaflet was handed out. Parents had
to give written informed consent prior to inclusion of
their children in the study. The vaccine information
recorded in the Personal Paediatric Record was requested.
The protocol was approved by the hospital's Research Eth-
ics Committee.
There were two criteria that led to children not receiving
the skin test: absence of written informed permission and
the existence of documented evidence of previous positive
TST.
Demographic data, past medical history and vaccination
status were recorded at study entry. As the latter was
deemed a key point in this research, we used three meth-
ods to improve its classification: a) certificate of BGC vac-
cination in the Personal Paediatric Record; b)
confirmation of BGC vaccination in the province register;
c) BGC scar. To classify a child in the non-BCG group, all
three methods had to have negative results and to classify
a child as BCG-vaccinated, at least two of three criteria had
to be positive. Those who did not fulfil these requirements
were considered to have an unknown vaccination status.
Skin tests
Intradermal injections with 0.1 ml of 2 TU PPD-RT23
tuberculin (bioequivalent to 5 TU PPD-S) and 0.1 ml of
RS-10 (M. avium) sensitin were used. The PPD RS-10 was
chosen because it is the most frequently isolated NTM
among the patients in our area. All tuberculin doses
belonged to the same lot (L-03) and sensitin doses came
from two lots (L-66 and L-68) [21]. Both tuberculin and
sensitin were prepared in and obtained from Statens
Serum Institut in Copenhagen, Denmark.
The tuberculin skin test was administered intradermally
[22] and the induration diameter was measured trans-
versely to the long axis of the arm 72 hours after applica-
tion.
Test application and reading were performed by a specifi-
cally trained team led by a specialist in respiratory medi-
cine and carried out by eight highly experienced nurses.
Four two-nurse groups were assembled, and each group
performed double and independent readings.
Statistical analysis
Descriptive analysis
The distribution of induration diameters was described
graphically using histograms and categorised using 5 mm-
intervals. The prevalence of LTBI was estimated using
three methods proposed in the literature [14,23,24]. The
first criterion, probably the most widely used, considers
all reactions ≥ 10 mm to be a marker of LTBI [14]. The sec-
ond one multiplies the proportion of reactions of size ≥
14 mm by 1.22 [24], and the last one, also known as the
mirror method, considers all indurations of 17 mm
counted once and indurations of ≥ 18 mm counted twice
to obtain the estimated number of infections [23,24].
Prevalence estimation using mixture models
This statistical approach has been extensively used in situ-
ations where a population is composed of several sub-
groups and the main issue is to find out which subgroup
one individual belongs to [25]. Neuenschwander et al
[15] applied this method to the analysis of LTBI preva-
lence, initially restricted to an unvaccinated population
and later on was extended to BCG-vaccinated populations
[16,17].
In our setting there are four possible subgroups according
to tuberculin induration response: individuals with null
induration after intradermal injection, individuals with
reaction due to NTM, individuals with reaction due to pre-
vious BCG vaccination and individuals with reaction due
to LTBI. Therefore, for BCG-vaccinated children the mix-
ture model will be comprised of four components in the
following sequential order [16]:
yj ≈ p0   + p1fEM (yj, θ1) + p2fBCG (yj, θ2) + p3fTB (yj, θ3)
 (1).
where yj represents the induration (in millimetres) for the
jth individual,   is an indicator function (takes value
1 if yj = 0 and 0 otherwise), fEM, fBCG and fTB represent the
distribution for each subgroup respectively: environmen-
tal mycobacteria reaction, BCG vaccination reaction and
LTBI reaction, being, p1, p2 and p3 the corresponding prob-
abilities and p0 = 1-(p1+ p2+p3) the probability associated
with null induration. For unvaccinated children, the fBCG
component is excluded resulting in a three-component
mixture model. In this model, the order of the compo-
nents reflects the assumption of increasing component
influences on the induration sizes. A similar model was
derived for the sensitin analysis, changing the component
order (fBCG, fTB and fEM).
I yj {} =0
I yj {} =0BMC Public Health 2006, 6:240 http://www.biomedcentral.com/1471-2458/6/240
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To analyse the tuberculin and sensitin responses, we
tested different parametric distributions for each compo-
nent, namely, normal, lognormal and Weibull, as sug-
gested by Neuenschwander et al. [16]. Their Bayesian
approach to parameter estimation led to convergence
problems in our data, and therefore we used an alternative
procedure within the empirical-Bayes framework to tackle
this problem: the EM estimation algorithm [26] in the
presence of incomplete data. This method need not incor-
porate prior information from subject-matter knowledge.
Parameter confidence intervals have been derived using
parametric bootstrap techniques [27], which have already
been used in mixture models applications [28]. These
methods were programmed in the freely available R soft-
ware [29] [see Additional file 2].
Results
I-Participation and BCG coverage
The survey fieldwork lasted five months as scheduled. Out
of the 8,430 children with a registered age of seven, 885
children were excluded for the following reasons: 638 for
not having obtained parents' written consent, 146
because the results of the tests could not be read, 21
because their vaccination status was unclassifiable and 95
for miscellaneous reasons (not being at school on the sur-
vey days, refusing the test, delay in receiving permission,
concurrent minor illness and history of preventive ther-
apy). Fifteen out of the 95 children were nevertheless
included because a previous tuberculin skin test reaction
size diameter had been recorded. Hence, our analyses are
based on 7,545 children (49.6% girls and 50.4% boys).
Table 1 displays the distribution of children according to
BCG vaccination status The ungrouped induration data is
provided in an additional [see Additional file 1].
II-Tuberculin and sensitin induration distributions
Using 5-mm interval categorisation (Table 2), it is clear
that the proportion of children having large induration
diameters is larger amongst BCG-vaccinated children.
Regardless of the vaccination status, more people react to
sensitin compared to tuberculin. Analyses of induration
distribution by sex and local health area did not show sta-
tistically significant differences.
III-Prevalence estimation using cut-off points
LTBI prevalences according to the commonly used cut-off
points are displayed in Table 3. Tuberculin results show
broad variation both according to vaccination status and
the cut-off point method selected. However, sensitin
results are quite stable regardless of vaccination status if
strict criteria are used. If a less stringent cut-off point is
chosen (including doubtful reactors, that is, those with 6–
11 mm induration), this stability is lost (unvaccinated
prevalence 11.59%, BCG-vaccinated prevalence 26.25%).
IV-Mixture models analysis
Among the theoretical distributions tested, the lognormal
and Weibull distributions seemed too flexible to provide
an adequate fit to our data, which are characterised by
showing a high proportion of zero indurations and not
having clearly identifiable modes for the components. In
contrast, the normal mixture models provided a proper fit
as reflected in comparatively good BIC results and good
adjustment to the observed distribution. In Table 4 we
provide the parameters' estimates of the component of
interest for each mixture model.
Tuberculin
The LTBI estimated prevalence in the BCG-vaccinated
group, although showing wide confidence intervals, is
higher than expected, especially as compared with its
counterpart prevalence figure in the unvaccinated group.
The observed induration distributions, the components of
the mixture model and the normal mixture model are rep-
resented in figures 1a and 1b. On one hand, the fit of the
mixture model is better in the BCG-vaccinated group,
because it is based on many more people and three com-
ponents are in use. On the other hand, in the unvacci-
nated group the components are more clearly
distinguished. Finally, figures 1c and 1d show the proba-
bility of LTBI as a function of induration among unvacci-
nated and BCG-vaccinated children respectively. It is
inferred from the first figure that indurations of 10 mm
carry an estimated probability of infection of 35%, and it
sharply arises as the induration increases from 10 to 14
mm, attaining a probability of infection of 97% for indu-
rations of 14 mm (see Figure 1c). In contrast, the indura-
tion needed to consider LTBI with a probability of 98%
Table 1: Children's distribution according to BCG vaccination status. % are row percentages.
Unvaccinated BCG-vaccinated Total Analysed
Sensitin 207
9.1%
2061
90.9%
2268
100%
Tuberculin 560
10.6%
4717
89.4%
5277
100%
TOTAL 767
10.2%
6778
89.8%
7545
100%BMC Public Health 2006, 6:240 http://www.biomedcentral.com/1471-2458/6/240
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among BCG-vaccinated people is 17 mm, 3 mm higher
than among unvaccinated.
Sensitin
M avium estimated prevalence (Table 4) is very similar
regardless of the vaccination status, around 7.5%. Simi-
larly to figures 1a and 1b, figures 2a and 2b show a better
fit of the mixture model in the BCG-vaccinated group. The
relative influence of the last component seems to be big-
ger for the sensitin test than for the tuberculin test.
Finally, figures 2c and 2d show the estimated probabilities
of M avium infection as a function of induration diame-
ters among unvaccinated and BCG-vaccinated children
respectively. The first figure shows that indurations of 8
mm carry a probability of infection of 25%, and it sharply
arises as the induration increases from 8 to 12 mm, attain-
ing a probability of infection of 98% for indurations of 12
mm. In contrast, the induration needed to consider M
avium infection with a probability of 98% among BCG-
vaccinated people is 15 mm, 3 mm higher than among
BCG-unvaccinated people.
Discussions and conclusions
We present the results of a tuberculin survey conducted in
a western European population characterised by a low-
intermediate TB incidence rate and high vaccination cov-
erage. The prevalences of LTBI and M avium infection are
estimated using different mixture models based on empir-
ical-Bayes estimation methods and compared to tradi-
tional estimation approaches. Additionally, a decision-aid
tool that capitalises on our own data and provides esti-
mates of the LTBI probability as a function of induration
instead of externally drawn cut-off proposals is presented.
This approach and the results obtained shed some light
on a complex issue with remarkable importance both
from clinical and public health perspectives.
In a setting with low-intermediate tuberculosis incidence
rates, high BCG coverage and a suspected presence of
MNT, data of good quality is essential. For this reason, we
designed this study taking special care in controlling the
quality of all its procedures. Skilled personnel were
enrolled, and a rigorous training process was undertaken
in order to ensure homogeneous administration and read-
ing of the derivatives [30]. Double and independent read-
ings are not, as far as we know, a routine procedure in
tuberculin and sensitin surveys.
Two features of this procedure deserve to be highlighted:
the rapid execution of the fieldwork which ensures stabil-
ity of conditions and the high participation rate (about
90%). Furthermore, the classification of vaccination sta-
tuses was very stringent, requiring at least two out of the
three criteria to be positive: certificate of BCG vaccination,
register confirmation and BCG scar [31].
Regarding the analysis of our TST results, it is remarkable
how the method used influences the estimated LTBI prev-
alence (Table 3). Almost 7% out of the 5277 children pre-
sented an induration size greater than or equal to 10 mm.,
and therefore this cut-off point does not seem to be spe-
cific enough in the detection of LTBI due to the presence
of NTM, BCG included [32]. When the "ø ≥ 14 mm ×
1.22" method is utilised, almost 3% of the children are
classified as infected by M tuberculosis. Using the mirror
Table 3: Different criteria for estimating prevalence of infection.
Tuberculin (0.1 ml 2TU-RT23) Sensitin (0.1 ml RS-10 M avium)
{ø ≥ 10 mm} * {ø ≥ 14 mm} × 1.22† {ø = 17 mm}+2 × {ø ≥ 18 mm} (Mirror method)‡ {ø ≥ 12 mm}§
Unvaccinated 1.43% 0.87% 0.71% 4.35%
BCG-vaccinated 7.63% 3.05% 1.55% 5.29%
Overall 6.97% 2.82% 1.46% 5.20%
*Bosman et al. (1998) (14).
†Salaniponi (2004) (24).
‡Styblo (1992) (23) and Bosman et al (1998) (24).
§Palmer and Edwards (1958) (13).
Table 2: Distribution of tuberculin and sensitin induration according to vaccination status.
Unvaccinated BCG-vaccinated
Induration (mm) 0 1–4 5–9 10–14 15–19 ≥ 20 0 1–4 5–9 10–14 15–19 ≥ 20
Tuberculin 527
94.1%
10
1.8%
15
2.7%
4
0.7%
3
0.5%
1
0.2%
3491
74%
218
4.6%
648
13.7%
266
5.6%
76
1.6%
18
0.4%
Sensitin 172
83.1%
8
3.9%
15
7.2%
8
3.9%
3
1.4%
1
0.5%
1334
64.7%
99
4.8%
406
19.7%
183
8.8%
35
1.7%
4
0.2%BMC Public Health 2006, 6:240 http://www.biomedcentral.com/1471-2458/6/240
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method [11,14,24], the LTBI prevalence would be 1.46%,
which is more in agreement with tuberculosis rates in our
region. Similar conclusions are reached by Salaniponi et
al. [24] who also faced similar problems when applying
these criteria in a different socio-demographic context.
Concerning environmental mycobacteria, there has not
been any study so far in our country with sensitin using a
sample as large as ours. Using the Palmer and Edwards cri-
teria [13] referred to by Bosman [14], at least 5.2% out of
the 2268 children who received sensitin as the first skin
test would be infected with M. avium. These children were
given TST one week later, and 3% of those who have had
an induration size equal to or larger than 5 mm to the sen-
sitin had null reaction to the tuberculin [33].
When comparing sensitin reactions with tuberculin ones
using 5 mm-interval induration categories, the proportion
of children with positive responses is clearly higher for the
sensitin (Table 2). These findings provide additional sup-
Induration distribution after tuberculin test and probability of LTBI as a function of induration diameter (mm) among unvacci- nated children (on the left) and BCG-vaccinated children (on the right) Figure 1
Induration distribution after tuberculin test and probability of LTBI as a function of induration diameter (mm) among unvacci-
nated children (on the left) and BCG-vaccinated children (on the right)
Table 4: Estimation of the parameters of the mixture models for the tuberculin and sensitin test.
Component Distribution Mean Variance p (%) 95% CI (p)
Tuberculin Test Unvaccinated LTBI Normal 13.38 5.86 1.51% (0.36, 3.10)
BCG-vaccinated LTBI Normal 12.95 4.84 4.88% (1.7, 5.8)
Sensitin Test Unvaccinated Environmental Mycobacteria Normal 12.53 4.33 7.01% (1.9,10.9)
BCG-vaccinated Environmental Mycobacteria Normal 11.84 3.84 7.77% (0.99,12.96)BMC Public Health 2006, 6:240 http://www.biomedcentral.com/1471-2458/6/240
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port to the idea that exposure to environmental mycobac-
teria is common in areas with low tuberculosis infection
rates and its effect should be accounted for when studying
LTBI prevalence [34,35].
Because of the difficulty of disentangling the origin of the
induration, we chose mixture models since they provide
an appropriate framework in situations where a measura-
ble variable (diameter of induration) is observed but the
subpopulation (representing the main cause of skin test
reaction) to which each individual belongs is unknown.
From this analysis, we can obtain not only prevalence esti-
mations but also information about the characteristics of
each subpopulation and the individual classification
probabilities. The estimation procedure of the parameters
of a mixture model in general can be difficult when the
number of components is large and/or when the compo-
nent distributions overlap to a great extent. For this rea-
son, it is more difficult to analyse BCG-vaccinated
children than unvaccinated children, where convergence
problems may arise in the estimation procedure. To min-
imise this problem, we analysed the data assuming several
distributions for the components. Eventually, the normal
mixture model provided both a reasonably good fit to the
data and clinically interpretable estimates. We fitted the
models using an empirical Bayesian analysis, which is a
time-saving alternative to the full Bayesian approach used
in this context by other authors [15], with the additional
advantage that there is no need to include prior knowl-
edge. To test this alternative estimation method for
robustness, it has also been applied to data obtained from
a rather different setting (summary data from the 1975
tuberculin survey in Korea analysed in [16] using full
Bayesian techniques and kindly provided by HL Rieder)
with very similar results and interpretation provided by
both methods.
Induration distribution after sensitin test and probability of M avium infection as a function of induration diameter (mm) among  unvaccinated children (on the left) and BCG-vaccinated children (on the right) Figure 2
Induration distribution after sensitin test and probability of M avium infection as a function of induration diameter (mm) among 
unvaccinated children (on the left) and BCG-vaccinated children (on the right).BMC Public Health 2006, 6:240 http://www.biomedcentral.com/1471-2458/6/240
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The interpretation of the mixture model results show that
the prevalence of LTBI among unvaccinated children is
about 1.5%. On the other hand, the prevalence of LTBI
among BCG-vaccinated children is about 4.9%. These fig-
ures, although lower than those obtained with the 10 mm
cut-off approach, still remain higher than we expected. We
think that this fact could be due to the low expected prev-
alence in this region, which makes it difficult for the mix-
ture model to estimate the relevant last component
(attributed to LTBI) with sufficient precision. In spite of
the fact that our study enrolled almost 90% of the target
population, it may be possible that among non-partici-
pants LTBI would be more frequent, contributing to the
imprecision of the last component. However, for popula-
tions with a higher presence of Mycobacterium tuberculo-
sis, the model should perform better, even in BCG-
vaccinated populations. This is reinforced by our findings
regarding M. avium infection, with a higher prevalence in
our study.
This mixture model approach, hence, in our view provides
important information concerning the effect of NTM
exposure on skin reactions and also about LTBI and M
avium infection probabilities according to induration size
(figures 1 and 2).
Focusing on the probability of LTBI (figures 1c and 1d), it
seems that on average, exposure to previous BCG vaccine
shifts around 3 mm towards greater induration size to
attain the same probability of infection in our study pop-
ulation. In particular, to attain a LTBI probability of
around 97%, the observed induration is 14 mm. for
unvaccinated and 17 mm. for BCG-vaccinated children,
results that were similar regardless of the distributional
assumptions adopted. This finding agrees with current
guidelines for LTBI treatment [2] and can be considered as
a useful, induration size calibrated aid to be used in addi-
tion to other epidemiological and clinical information to
make individual decisions.
Regarding M avium infection, some 7–8% of the children
could be infected according to the mixture model results,
without significant differences among BCG-vaccinated
and unvaccinated, with both prevalences being higher
than those obtained from the TST. BCG vaccine seems to
have a similar effect on sensitin and tuberculin induration
responses, requiring an upward shift of an average of
about 3 mm to attain the same probability of infection.
Comparing the probability of infection with M tuberculosis
and M avium as a function of induration, it is clear that the
diameters needed to consider infection are lower for sen-
sitin than for tuberculin. According to the results for the
sensitin test, 8 mm of induration for unvaccinated and 10
mm for BCG-vaccinated children show a probability of M
avium infection of about 25%, attaining a probability of
infection above 98% with indurations of 12 and 15 mm
for unvaccinated and BCG-vaccinated respectively.
In summary, we can conclude that the survey carried out
using both tuberculin and sensitin skin tests supports the
fact that the presence of Environmental Mycobacteria in
our region cannot be neglected. The approach proposed
here to analyse the results of the TST provides an alterna-
tive method for LTBI prevalence estimation based on the
information obtained from our own local setting data
instead of using external criteria and endorses current
LTBI treatment decisions in populations similar to ours
[2]. Recently developed and currently available blood
tests represent the biggest change since introduction of the
TST test for the diagnostic and therapeutic management of
LTBI in developed countries [4]. CDC guidelines recom-
mend utilising whole blood IFN-γ test QFT-G instead of
TST although a combined use of both tests may increase
the diagnostic yield insomuch as specificity is improved
[36]. This combined strategy may also maximise cost-
effectiveness [37,38], at least in adults as recent research in
children suggests in them tests interpretation can be more
complex [39]. If this is the case our method may add val-
uable information and we recommend its use to analyse
TBC surveys, especially in areas with intermediate-high
TBC prevalences in order to better deal with this still chal-
lenging problem.
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